Seegene Inc (096530):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Seegene Inc (096530) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6494
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions using Real-time PCR methods. Seegene’s IVD reagents are used in testing respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis and sepsis and meningitis pathogen, among others. The company caters to commercial laboratories, DNA chip-based companies and molecular diagnostic companies. It has operations in the US, Canada, Germany and others. Seegene is headquartered in Seoul, South Korea.

Seegene Inc (096530) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Inc, Medical Equipment, Deal Details 10
Partnerships 10
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d’Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc – Key Competitors 21
Seegene Inc – Key Employees 22
Seegene Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Product News 24
Jan 03, 2018: Seegene develops world’s first multiplex MDx assays with its AI system 24
Apr 26, 2017: Seegene Unlocks the Door to the Next Level of the Real-time PCR Business 25
Feb 14, 2017: Seegene Develops New Normalization Software Technology for Molecular Diagnosis 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Seegene Inc, Medical Equipment, Key Facts, 2017 2
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Deals By Market, 2012 to YTD 2018 8
Seegene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 10
Seegene to Enter into Agreement with Hamilton 11
Seegene Enters into Agreement with Thermo Fisher Scientific 12
Seegene and Institut Catala d'Oncologia Enter into Partnership 13
Seegene Enters into Agreement with Hologic 14
Seegene Forms Joint Venture with Biodist 15
Seegene Enters into Co-Development Agreement with BD Life Sciences 16
Seegene To Enter Into Development Agreement For Real-Time Array Technology 17
Seegene Enters Into Distribution Agreement With Eidia For Multiplex Molecular Diagnostic Tests 18
Seegene And Selventa Enter Into Agreement To Develop Molecular Diagnostics 19
Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing 20
Seegene Inc, Key Competitors 21
Seegene Inc, Key Employees 22
Seegene Inc, Other Locations 23
Seegene Inc, Subsidiaries 23
Seegene Inc, Joint Venture 23

List of Figures
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Seegene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Seegene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Seegene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Seegene Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Seegene Inc (096530):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Economist Group Ltd:企業の戦略的SWOT分析
    The Economist Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Murata Manufacturing Co Ltd (6981):医療機器:M&Aディール及び事業提携情報
    Summary Murata Manufacturing Co., Ltd. (Murata) is an electronic component manufacturing company that designs, manufactures, and supplies a range of advanced electronic materials, components, and multi-functional, high-density modules. Its product portfolio includes capacitors, inductors, resistors, …
  • 3i Group Plc:企業のM&A・事業提携・投資動向
    3i Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3i Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • ION Geophysical Corp (IO):企業の財務・戦略的SWOT分析
    ION Geophysical Corp (IO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Canadian Tire Corporation, Limited:戦略・SWOT・企業財務分析
    Canadian Tire Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Tire Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sanofi (SAN):医療機器:M&Aディール及び事業提携情報
    Summary Sanofi is a healthcare company that researches, develops, manufactures and markets a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protect …
  • Qurate Retail, Inc.:企業の戦略・SWOT・財務情報
    Qurate Retail, Inc. - Strategy, SWOT and Corporate Finance Report Summary Qurate Retail, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Manhattan Scientifics Inc (MHTX):企業の財務・戦略的SWOT分析
    Summary Manhattan Scientifics Inc (Manhattan Scientifics) is a diversified company. The company transfers and commercializes technologies in nanomedicine space. It has acquired technologies in the fields of holographic data storage, alternative energy, water purification, advanced computer haptics a …
  • DMC Global Inc (BOOM):企業の財務・戦略的SWOT分析
    Summary DMC Global Inc (DMC), formerly Dynamic Materials Corp is an industrial equipment and machinery company. It manufactures, distributes, and markets explosion welded clad metal plates. The company’s products include oilfield products, explosive metalworking equipment, and AMK welding equipment, …
  • PPL Corp (PPL):企業の財務・戦略的SWOT分析
    PPL Corp (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • AGCO Corporation:企業の戦略・SWOT・財務分析
    AGCO Corporation - Strategy, SWOT and Corporate Finance Report Summary AGCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SMART Technologies Inc.:企業の戦略的SWOT分析
    SMART Technologies Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • TMX Group Limited (X):企業の財務・戦略的SWOT分析
    TMX Group Limited (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ImevaX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops novel vaccines to prevent chronic and nosocomial infections. Its lead product candidate IMX101, an immune evasion vaccine, is indicated for the treatment of Helicobacter pylori. Its pipeline products include IMA101 mucosal adj …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務情報
    AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tobu Railway Co Ltd:企業の戦略・SWOT・財務分析
    Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hannover Ruck SE:企業の戦略・SWOT・財務情報
    Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report Summary Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Greenhill & Co Inc:企業の戦略・SWOT・財務情報
    Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report Summary Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bahamas Petroleum Company Plc (BPC):石油・ガス:M&Aディール及び事業提携情報
    Summary Bahamas Petroleum Company Plc (Bahamas Petroleum), formerly BPC plc, is an oil and gas exploration company. The company invests in an offshore oil exploration programme in licence areas in the territorial waters and maritime Exclusive Economic Zone of The Bahamas. It holds interests in five …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆